✦ LIBER ✦

Mitigating the Cardiovascular Risk of Anemia in Patients with Type 2 Diabetes and CKD: Does Darbepoetin Help? The TREAT Trial

✍ Scribed by Christi Hayes; Anis Alam; Julie Black-Peart; Samy I. McFarlane

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemoglobin Stability in Patients With An

✍ Skali, Hicham; Lin, Julie; Pfeffer, Marc A.; Chen, Chao-Yin; Cooper, Mark E.; Mc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 550 KB

Predictors of fatal and nonfatal cardiov

✍ John J.V. McMurray; Hajime Uno; Petr Jarolim; Akshay S. Desai; Dick de Zeeuw; Ka 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 463 KB

Cardiovascular outcomes in the Irbesarta

✍ T. Berl; L.G. Hunsicker; J.B. Lewis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Anemia normalization in patients with ty

✍ Emmanuel Villar; Michel Lièvre; Michèle Kessler; Vincent Lemaître; Eric Alamarti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Resting heart rate and the risk of death

✍ G. S. Hillis; M. Woodward; A. Rodgers; C. K. Chow; Q. Li; S. Zoungas; A. Patel; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 269 KB

The effects of rosiglitazone on atherosc

✍ M. S. Yee; D. V. Pavitt; S. Dhanjil; I. F. Godsland; W. Richmond; D. G. Johnston 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB